The expression of MIR-150 in indolent primary cutaneous B-cell lymphoma (10) and chronic lymphocytic leukemia (11) is inversely related to patients’ survival time, helping the prognosis of the disease. Here, MIR150 is linked to B-cell chronic lymphocytic leukemia.